Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind placebo-controlled study of oral nickel desensitization in systemic nickel allergy syndrome
2009-013923-43Phase 3Completed
- Sponsor
- Lofarma S.p.A.
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nickel sulfate in Systemic Nickel Allergy Syndrome (SNAS) (4 arms), sponsored by Lofarma S.p.A. Primary endpoint: Primary efficacy endpoint. Started Feb 2010; status: completed.
02
Drugs
nickel sulfate
03
Conditions
Systemic Nickel Allergy Syndrome (SNAS)
Beyond the preview
Go deeper on 2009-013923-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013923-43.